BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Kadin ME, Pavlov IY, Delgado JC, Vonderheid EC. High soluble CD30, CD25, and IL-6 may identify patients with worse survival in CD30+ cutaneous lymphomas and early mycosis fungoides. J Invest Dermatol 2012;132:703-10. [PMID: 22071475 DOI: 10.1038/jid.2011.351] [Cited by in Crossref: 25] [Cited by in F6Publishing: 17] [Article Influence: 2.5] [Reference Citation Analysis]
Number Citing Articles
1 Hughes CF, Newland K, Mccormack C, Lade S, Prince HM. Mycosis fungoides and Sézary syndrome: Current challenges in assessment, management and prognostic markers: Mycosis fungoides and Sézary syndrome. Australasian Journal of Dermatology 2016;57:182-91. [DOI: 10.1111/ajd.12349] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
2 van Anrooij B, Kluin PM, Oude Elberink JN, Kluin-Nelemans JC. CD30 in systemic mastocytosis. Immunol Allergy Clin North Am 2014;34:341-55. [PMID: 24745678 DOI: 10.1016/j.iac.2014.01.006] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 2.4] [Reference Citation Analysis]
3 Olszewska B, Gleń J, Zabłotna M, Nowicki RJ, Sokołowska-Wojdyło M. The polymorphisms of IL-6/STAT3 signaling pathway may contribute to cutaneous T-cell lymphomas susceptibility. Arch Dermatol Res 2021;313:25-31. [PMID: 32270320 DOI: 10.1007/s00403-020-02062-5] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
4 Gru AA, Kim J, Pulitzer M, Guitart J, Battistella M, Wood GS, Cerroni L, Kempf W, Willemze R, Pawade J, Querfeld C, Schaffer A, Pincus L, Tetzlaff M, Duvic M, Scarisbrick J, Porcu P, Mangold AR, DiCaudo DJ, Shinohara M, Hong EK, Horton B, Kim YH. The Use of Central Pathology Review With Digital Slide Scanning in Advanced-stage Mycosis Fungoides and Sézary Syndrome: A Multi-institutional and International Pathology Study. Am J Surg Pathol 2018;42:726-34. [PMID: 29543675 DOI: 10.1097/PAS.0000000000001041] [Cited by in Crossref: 12] [Cited by in F6Publishing: 2] [Article Influence: 6.0] [Reference Citation Analysis]
5 Wang Y, Gu X, Zhang G, Wang L, Wang T, Zhao Y, Zhang X, Zhou Y, Kadin M, Tu P. SATB1 overexpression promotes malignant T-cell proliferation in cutaneous CD30+ lymphoproliferative disease by repressing p21. Blood 2014;123:3452-61. [PMID: 24747435 DOI: 10.1182/blood-2013-10-534693] [Cited by in Crossref: 25] [Cited by in F6Publishing: 25] [Article Influence: 3.6] [Reference Citation Analysis]
6 Orofino N, Guidotti F, Cattaneo D, Sciumè M, Gianelli U, Cortelezzi A, Iurlo A. Marked eosinophilia as initial presentation of breast implant-associated anaplastic large cell lymphoma. Leukemia & Lymphoma 2016;57:2712-5. [DOI: 10.3109/10428194.2016.1160079] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 3.2] [Reference Citation Analysis]
7 Xu ML, Gabali A, Hsi ED, Fedoriw Y, Vij K, Salama ME, Ramchandren R, O'Malley D, Wick MR, Battistella M, Gru AA. Practical Approaches on CD30 Detection and Reporting in Lymphoma Diagnosis. Am J Surg Pathol 2020;44:e1-e14. [PMID: 31567279 DOI: 10.1097/PAS.0000000000001368] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
8 Vonderheid EC, Pavlov I, Delgado JC, Martins TB, Telang GH, Hess AD, Kadin ME. Prognostic factors and risk stratification in early mycosis fungoides. Leukemia & Lymphoma 2013;55:44-50. [DOI: 10.3109/10428194.2013.790541] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 2.0] [Reference Citation Analysis]
9 Merlio JP, Kadin ME. Cytokines, Genetic Lesions and Signaling Pathways in Anaplastic Large Cell Lymphomas. Cancers (Basel) 2021;13:4256. [PMID: 34503066 DOI: 10.3390/cancers13174256] [Reference Citation Analysis]
10 Nishiwaki U, Nakayama S, Yokote T, Hiraoka N, Iwaki K, Hatooka J, Hirata Y, Fumimoto A, Miyoshi T, Masuda Y, Fujimoto M, Akioka T, Tsuji M, Hanafusa T. Multiple cytokine-producing primary cutaneous anaplastic large cell lymphoma. Ann Hematol 2016;95:1369-70. [PMID: 27256346 DOI: 10.1007/s00277-016-2714-y] [Reference Citation Analysis]
11 Kadin ME. What Cytokines Can Tell Us About the Pathogenesis of Breast Implant-Associated Anaplastic Large Cell Lymphoma (BIA-ALCL). Aesthetic Surgery Journal 2019;39:S28-35. [DOI: 10.1093/asj/sjy250] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 5.0] [Reference Citation Analysis]
12 Kadin ME, Hamilton RG, Vonderheid EC. Evidence linking atopy and staphylococcal superantigens to the pathogenesis of lymphomatoid papulosis, a recurrent CD30+ cutaneous lymphoproliferative disorder. PLoS One 2020;15:e0228751. [PMID: 32049976 DOI: 10.1371/journal.pone.0228751] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
13 Chu Y, Zhou X, Wang X. Antibody-drug conjugates for the treatment of lymphoma: clinical advances and latest progress. J Hematol Oncol 2021;14:88. [PMID: 34090506 DOI: 10.1186/s13045-021-01097-z] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
14 Vonderheid EC, Martinez AR. Prognostic Significance of Serum Copper in Patients With Cutaneous T-cell Lymphoma. Clin Lymphoma Myeloma Leuk 2019;19:228-238.e4. [PMID: 30745139 DOI: 10.1016/j.clml.2018.12.020] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
15 Inghirami G, Chan WC, Pileri S; AIRC 5xMille consortium ‘Genetics-driven targeted management of lymphoid malignancies’. Peripheral T-cell and NK cell lymphoproliferative disorders: cell of origin, clinical and pathological implications. Immunol Rev 2015;263:124-59. [PMID: 25510275 DOI: 10.1111/imr.12248] [Cited by in Crossref: 23] [Cited by in F6Publishing: 20] [Article Influence: 3.8] [Reference Citation Analysis]
16 Kadin ME, Morgan J, Xu H, Epstein AL, Sieber D, Hubbard BA, Adams WP, Bacchi CE, Goes JC, Clemens MW, Medeiros LJ, Miranda RN. IL-13 is produced by tumor cells in breast implant–associated anaplastic large cell lymphoma: implications for pathogenesis. Human Pathology 2018;78:54-62. [DOI: 10.1016/j.humpath.2018.04.007] [Cited by in Crossref: 41] [Cited by in F6Publishing: 38] [Article Influence: 13.7] [Reference Citation Analysis]
17 Scarisbrick J, Kim Y, Whittaker S, Wood G, Vermeer M, Prince H, Quaglino P. Prognostic factors, prognostic indices and staging in mycosis fungoides and Sézary syndrome: where are we now? Br J Dermatol 2014;170:1226-36. [DOI: 10.1111/bjd.12909] [Cited by in Crossref: 81] [Cited by in F6Publishing: 78] [Article Influence: 11.6] [Reference Citation Analysis]